Literature DB >> 28322927

Pathogenic and immunosuppressive properties of mycobacterial phenolic glycolipids.

Reid Oldenburg1, Caroline Demangel2.   

Abstract

Phenolic glycolipids (PGL) are polyketide synthase products that are uniquely produced by a subset of pathogenic mycobacteria and are displayed at the bacterial cell surface, in a strategic position to interfere with host immune cells. Their expression has been associated with enhanced mycobacterial virulence in vivo, and suppression of the inflammatory responses of host phagocytes in vitro. In this review, we will present our current understanding of the mode of operation of PGL, along with functional evidence that demonstrates the evolutionary advantage conferred by PGL production for host cell invasion, intracellular persistence and evasion of host immune and bactericidal responses.
Copyright © 2017 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Keywords:  Immunomodulation; Mycobacteria; Phenolic glycolipids

Mesh:

Substances:

Year:  2017        PMID: 28322927     DOI: 10.1016/j.biochi.2017.03.012

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  5 in total

1.  Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry.

Authors:  Nelson Enrique Arenas; Gilles Pieffet; Cristian Rocha-Roa; Martha Inírida Guerrero
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-18       Impact factor: 2.747

2.  Mycobacterial Phenolic Glycolipids Selectively Disable TRIF-Dependent TLR4 Signaling in Macrophages.

Authors:  Reid Oldenburg; Veronique Mayau; Jacques Prandi; Ainhoa Arbues; Catherine Astarie-Dequeker; Christophe Guilhot; Catherine Werts; Nathalie Winter; Caroline Demangel
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

Review 3.  Lipoarabinomannan in Active and Passive Protection Against Tuberculosis.

Authors:  Margarida Correia-Neves; Christopher Sundling; Andrea Cooper; Gunilla Källenius
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

4.  Editorial: Mycobacterial Glycolipids-Role in Immunomodulation and Targets for Vaccine Development.

Authors:  Gunilla Källenius; Jérôme Nigou; Andrea Cooper; Margarida Correia-Neves
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

5.  Antimicrobial activity of the volatile substances from essential oils.

Authors:  Mareshah Abers; Sydney Schroeder; Linna Goelz; Adrienne Sulser; Tiffany St Rose; Keely Puchalski; Jeffrey Langland
Journal:  BMC Complement Med Ther       Date:  2021-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.